NGL Fine-Chem Limited (BOM:524774)
2,903.00
-137.55 (-4.52%)
At close: Nov 16, 2026
NGL Fine-Chem Market Cap
NGL Fine-Chem has a market cap or net worth of 17.93 billion as of November 17, 2026. It is the 20,658th most valuable company in the world and the 1,310th biggest in India. Its market cap has increased by 108.85% in one year.
Market Cap
17.93B
Enterprise Value
18.76B
Revenue
5.74B
Global Rank
Country Rank
#1,310 India
PE Ratio
28.07
ChartMarket Cap Chart
Since December 24, 2004, NGL Fine-Chem's market cap has increased from 80.40M to 17.93B, an increase of 22,206.97%. That is a compound annual growth rate of 27.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 17.93B | 106.03% |
| Dec 31, 2025 | 8.70B | -21.72% |
| Dec 31, 2024 | 11.12B | -19.33% |
| Dec 29, 2023 | 13.79B | 44.38% |
| Dec 30, 2022 | 9.55B | -42.81% |
| Dec 31, 2021 | 16.70B | 140.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Symbiotec Pharmalab | 103.54B |
| Suven Life Sciences | 78.67B |
| IOL Chemicals and Pharmaceuticals | 59.18B |
| Gujarat Themis Biosyn | 50.66B |
| Bajaj HealthCare | 10.86B |
| Shree Ganesh Remedies | 8.40B |
| Influx Healthtech | 6.49B |
| Ennature Bio Pharma Private | 4.67B |